QQQ   353.14 (+1.48%)
AAPL   179.84 (+1.46%)
MSFT   333.41 (+1.53%)
META   273.78 (+3.42%)
GOOGL   123.46 (+0.48%)
AMZN   123.34 (+2.29%)
TSLA   209.72 (+2.84%)
NVDA   399.08 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.25 (+4.65%)
AMD   120.76 (+2.16%)
T   15.83 (+0.64%)
F   12.16 (+1.33%)
MU   69.37 (+1.72%)
CGC   0.83 (-0.26%)
GE   105.12 (+3.54%)
DIS   88.97 (+1.15%)
AMC   4.58 (+1.78%)
PFE   38.06 (+0.11%)
PYPL   63.41 (+2.29%)
NFLX   405.50 (+2.60%)
QQQ   353.14 (+1.48%)
AAPL   179.84 (+1.46%)
MSFT   333.41 (+1.53%)
META   273.78 (+3.42%)
GOOGL   123.46 (+0.48%)
AMZN   123.34 (+2.29%)
TSLA   209.72 (+2.84%)
NVDA   399.08 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.25 (+4.65%)
AMD   120.76 (+2.16%)
T   15.83 (+0.64%)
F   12.16 (+1.33%)
MU   69.37 (+1.72%)
CGC   0.83 (-0.26%)
GE   105.12 (+3.54%)
DIS   88.97 (+1.15%)
AMC   4.58 (+1.78%)
PFE   38.06 (+0.11%)
PYPL   63.41 (+2.29%)
NFLX   405.50 (+2.60%)
QQQ   353.14 (+1.48%)
AAPL   179.84 (+1.46%)
MSFT   333.41 (+1.53%)
META   273.78 (+3.42%)
GOOGL   123.46 (+0.48%)
AMZN   123.34 (+2.29%)
TSLA   209.72 (+2.84%)
NVDA   399.08 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.25 (+4.65%)
AMD   120.76 (+2.16%)
T   15.83 (+0.64%)
F   12.16 (+1.33%)
MU   69.37 (+1.72%)
CGC   0.83 (-0.26%)
GE   105.12 (+3.54%)
DIS   88.97 (+1.15%)
AMC   4.58 (+1.78%)
PFE   38.06 (+0.11%)
PYPL   63.41 (+2.29%)
NFLX   405.50 (+2.60%)
QQQ   353.14 (+1.48%)
AAPL   179.84 (+1.46%)
MSFT   333.41 (+1.53%)
META   273.78 (+3.42%)
GOOGL   123.46 (+0.48%)
AMZN   123.34 (+2.29%)
TSLA   209.72 (+2.84%)
NVDA   399.08 (+5.48%)
NIO   7.60 (+0.93%)
BABA   83.25 (+4.65%)
AMD   120.76 (+2.16%)
T   15.83 (+0.64%)
F   12.16 (+1.33%)
MU   69.37 (+1.72%)
CGC   0.83 (-0.26%)
GE   105.12 (+3.54%)
DIS   88.97 (+1.15%)
AMC   4.58 (+1.78%)
PFE   38.06 (+0.11%)
PYPL   63.41 (+2.29%)
NFLX   405.50 (+2.60%)
NASDAQ:WINT

Windtree Therapeutics (WINT) Stock Forecast, Price & News

$1.31
+0.03 (+2.30%)
(As of 03:09 PM ET)
Compare
Today's Range
$1.27
▼
$1.32
50-Day Range
$1.23
▼
$8.27
52-Week Range
$1.22
▼
$44.00
Volume
114,083 shs
Average Volume
558,748 shs
Market Capitalization
$6.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Windtree Therapeutics MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
4.25% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$2,485 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.12) to ($1.43) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars

See Top Rated MarketRank™ Stocks Here

WINT stock logo

About Windtree Therapeutics (NASDAQ:WINT) Stock

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Receive WINT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

WINT Stock News Headlines

May 15, 2023 | finance.yahoo.com
Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
May 15, 2023 | finance.yahoo.com
Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
June 1, 2023 | Edge On The Street (Ad)
AI Getting Close to Thinking Like Humans
Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.
May 12, 2023 | americanbankingnews.com
Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Up 136.9% in April
April 27, 2023 | finance.yahoo.com
Windtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime
April 24, 2023 | finance.yahoo.com
Windtree Therapeutics Announces Closing of $12.42 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
April 21, 2023 | benzinga.com
Premarket Mover: Windtree Therapeutics Inc (WINT) Down 20.27%
April 21, 2023 | marketwatch.com
Windtree Therapeutics Shares Hit New Lows After Offering Priced >WINT
June 1, 2023 | Edge On The Street (Ad)
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
April 20, 2023 | msn.com
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 20, 2023 | msn.com
2LVS, META : Benzinga Pro's Top 5 Stocks To Watch For Thursday, April 20, 2...
April 20, 2023 | msn.com
Why Windtree Therapeutics Stock Is Tumbling Today
April 20, 2023 | msn.com
Windtree Therapeutics stock slides after pricing $10.8M equity offering
April 20, 2023 | finance.yahoo.com
Windtree Therapeutics Announces Pricing of Upsized $10.8 Million Underwritten Public Offering
April 19, 2023 | marketwatch.com
Windtree Therapeutics Shares Double After New Patent for SERCA2a Activator
April 17, 2023 | investorplace.com
Why Is Windtree Therapeutics (WINT) Stock Up 190% Today?
April 17, 2023 | finance.yahoo.com
Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent
April 5, 2023 | americanbankingnews.com
Windtree Therapeutics (NASDAQ:WINT) Issues Quarterly Earnings Results
April 3, 2023 | finance.yahoo.com
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
April 3, 2023 | finance.yahoo.com
Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates
March 30, 2023 | americanbankingnews.com
Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Drops By 53.0%
March 13, 2023 | finance.yahoo.com
Windtree Regains Compliance with Nasdaq
March 6, 2023 | finance.yahoo.com
Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime
February 28, 2023 | finance.yahoo.com
Windtree Announces Publication on its SERCA2a Activator Drug Candidate for Chronic and Acute Heart Failure
February 27, 2023 | finance.yahoo.com
Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 2023 Technology and Heart Failure Therapeutics Conference
February 24, 2023 | morningstar.com
Thinking about buying stock in Windtree Therapeutics, Intel, IQIYI, Hoth Therapeutics, or Credit Suisse?
February 24, 2023 | finance.yahoo.com
Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office
See More Headlines

WINT Price History

WINT Company Calendar

Last Earnings
4/03/2023
Today
6/01/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:WINT
CUSIP
N/A
CIK
946486
Web
www.windtreetx.com
Phone
(215) 488-9300
Fax
215-488-9301
Employees
31
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($53.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-39,210,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-175.60%
Return on Assets
-54.45%

Debt

Debt-to-Equity Ratio
2.13
Current Ratio
1.89
Quick Ratio
1.89

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.53 per share
Price / Book
0.84

Miscellaneous

Outstanding Shares
4,595,000
Free Float
3,923,000
Market Cap
$5.88 million
Optionable
Not Optionable
Beta
0.17

Key Executives

  • Craig E. FraserCraig E. Fraser
    President, Chief Executive Officer & Director
  • Eric L. Curtis
    Chief Operating Officer & Senior Vice President
  • John Andrew Tattory
    Chief Financial Officer
  • Steven G. Simonson
    Chief Medical Officer & Senior Vice President
  • Joseph Soffer
    Executive Director-Clinical Development

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













WINT Stock - Frequently Asked Questions

How have WINT shares performed in 2023?

Windtree Therapeutics' stock was trading at $8.50 at the beginning of the year. Since then, WINT stock has decreased by 84.9% and is now trading at $1.28.
View the best growth stocks for 2023 here.

Are investors shorting Windtree Therapeutics?

Windtree Therapeutics saw a increase in short interest in May. As of May 15th, there was short interest totaling 195,100 shares, an increase of 64.4% from the April 30th total of 118,700 shares. Based on an average trading volume of 865,500 shares, the short-interest ratio is presently 0.2 days.
View Windtree Therapeutics' Short Interest.

When is Windtree Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our WINT earnings forecast.

How were Windtree Therapeutics' earnings last quarter?

Windtree Therapeutics, Inc. (NASDAQ:WINT) issued its quarterly earnings data on Monday, April, 3rd. The company reported ($13.01) EPS for the quarter, missing the consensus estimate of ($10.50) by $2.51.

When did Windtree Therapeutics' stock split?

Shares of Windtree Therapeutics reverse split on the morning of Thursday, February 23rd 2023. The 1-50 reverse split was announced on Thursday, February 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What is Windtree Therapeutics' stock symbol?

Windtree Therapeutics trades on the NASDAQ under the ticker symbol "WINT."

How do I buy shares of Windtree Therapeutics?

Shares of WINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Windtree Therapeutics' stock price today?

One share of WINT stock can currently be purchased for approximately $1.28.

How much money does Windtree Therapeutics make?

Windtree Therapeutics (NASDAQ:WINT) has a market capitalization of $5.88 million. The company earns $-39,210,000.00 in net income (profit) each year or ($53.77) on an earnings per share basis.

How can I contact Windtree Therapeutics?

Windtree Therapeutics' mailing address is 2600 KELLY ROAD SUITE 100, WARRINGTON PA, 18976. The official website for the company is www.windtreetx.com. The company can be reached via phone at (215) 488-9300, via email at ir@windtreetx.com, or via fax at 215-488-9301.

This page (NASDAQ:WINT) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -